Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1973 1
1975 2
1976 2
1977 1
1978 2
1980 3
1981 3
1982 3
1983 4
1984 7
1985 5
1986 4
1987 8
1988 10
1989 15
1990 12
1991 20
1992 15
1993 9
1994 13
1995 11
1996 20
1997 18
1998 23
1999 17
2000 8
2001 12
2002 13
2003 13
2004 16
2005 11
2006 9
2007 7
2008 17
2009 14
2010 6
2011 8
2012 12
2013 18
2014 21
2015 18
2016 12
2017 5
2018 9
2019 10
2020 7
2021 7
2022 11
2023 19
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

500 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial.
Navarra SV, Guzmán RM, Gallacher AE, Hall S, Levy RA, Jimenez RE, Li EK, Thomas M, Kim HY, León MG, Tanasescu C, Nasonov E, Lan JL, Pineda L, Zhong ZJ, Freimuth W, Petri MA; BLISS-52 Study Group. Navarra SV, et al. Among authors: nasonov e. Lancet. 2011 Feb 26;377(9767):721-31. doi: 10.1016/S0140-6736(10)61354-2. Epub 2011 Feb 4. Lancet. 2011. PMID: 21296403 Clinical Trial.
Olokizumab versus Placebo or Adalimumab in Rheumatoid Arthritis.
Smolen JS, Feist E, Fatenejad S, Grishin SA, Korneva EV, Nasonov EL, Samsonov MY, Fleischmann RM; CREDO2 Group. Smolen JS, et al. Among authors: nasonov el. N Engl J Med. 2022 Aug 25;387(8):715-726. doi: 10.1056/NEJMoa2201302. N Engl J Med. 2022. PMID: 36001712 Clinical Trial.
[Autoimmunity in rheumatology: A review].
Nasonov EL. Nasonov EL. Ter Arkh. 2023 Dec 28;95(12):1056-1063. doi: 10.26442/00403660.2023.12.202501. Ter Arkh. 2023. PMID: 38158939 Review. Russian.
Coronavirus Infection 2019 (COVID-19) and Autoimmunity.
Nasonov EL, Samsonov MY, Lila AM. Nasonov EL, et al. Her Russ Acad Sci. 2022;92(4):398-403. doi: 10.1134/S1019331622040062. Epub 2022 Sep 6. Her Russ Acad Sci. 2022. PMID: 36091857 Free PMC article.
[Meloxicam in Russia: 20 years together].
Karateev AE, Nasonov EN. Karateev AE, et al. Among authors: nasonov en. Ter Arkh. 2016;88(12):149-158. doi: 10.17116/terarkh20168812149-158. Ter Arkh. 2016. PMID: 28635891 Review. Russian.
Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor inhibitor therapy: efficacy and safety results of a randomised controlled phase III study.
Feist E, Fatenejad S, Grishin S, Korneva E, Luggen ME, Nasonov E, Samsonov M, Smolen JS, Fleischmann RM. Feist E, et al. Among authors: nasonov e. Ann Rheum Dis. 2022 Dec;81(12):1661-1668. doi: 10.1136/ard-2022-222630. Epub 2022 Sep 15. Ann Rheum Dis. 2022. PMID: 36109142 Free PMC article. Clinical Trial.
500 results